Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3741131015 | Product containing only linagliptin and metformin in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3741132010 | Linagliptin and metformin only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3741131015 | Product containing only linagliptin and metformin in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3741132010 | Linagliptin and metformin only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5569121000241116 | produit contenant seulement de la linagliptine et de la metformine sous forme orale | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
5569121000241116 | produit contenant seulement de la linagliptine et de la metformine sous forme orale | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) | Is a | True | Linagliptin and metformin only product in oral dose form | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug) | Is a | True | Linagliptin and metformin only product in oral dose form | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug) | Is a | True | Linagliptin and metformin only product in oral dose form | Inferred relationship | Existential restriction modifier (core metadata concept) |
This concept is not in any reference sets